Neurology Today in 5

Neurology Today in 5

American Academy of Neurology

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

Categorieën: Gezondheid

Luister naar de laatste aflevering:

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.

Vorige afleveringen

  • 224 - ME/CFS and long COVID; negative outcomes for ALS drug; donanemab 
    Thu, 18 Apr 2024 - 0h
  • 223 - BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine 
    Thu, 04 Apr 2024 - 0h
  • 222 - SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens 
    Thu, 21 Mar 2024 - 0h
  • 221 - AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy 
    Thu, 07 Mar 2024 - 0h
  • 220 - Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders 
    Mon, 12 Feb 2024 - 0h
Meer afleveringen weergeven

Meer Belgische gezondheidpodcasts

Meer internationale gezondheidpodcasts

Kies een categorie